New feature: Customize your PLUS research experience with My Preferences. Learn more.
Skip to main content

Sanofi's Acquisition of Genzyme - The CVR


Book Publication Date: Jul 2020
Description: Excerpts relating to the structure of Sanofi-Aventis' 2011 acquisition of Genzyme, a publicly held Massachusetts corporation, in a combination exchange offer followed by a second-step merger
Type: Contract Clauses
PLI Item #: 41252
Practice Area: Corporate & Securities
Keywords: "CVR"; "contingent valuation right"; "Sanofi's Acquisition of Genzyme"; "Genzyme common stock"; agreement governing Exchange Offer; issuance of CVRs; "transferability of CVRs"; reporting obligations; amendment of CVR agreement without the consent of CVR holders; parent purchase and cancellation right upon CVR failure event

Thank you for exploring PLI PLUS.
The content on this page is only available to subscribers.

To learn more about PLI PLUS subscriptions
please click on the link below or contact us at PLUS@pli.edu.